The Discounted Cash Flow (DCF) valuation of Guizhou Sanli Pharmaceutical Co Ltd (603439.SS) is 8.94 CNY. With the latest stock price at 13.03 CNY, the upside of Guizhou Sanli Pharmaceutical Co Ltd based on DCF is -31.4%.
Based on the latest price of 13.03 CNY and our DCF valuation, Guizhou Sanli Pharmaceutical Co Ltd (603439.SS) is a sell. selling 603439.SS stocks now will result in a potential gain of 31.4%.
| Range | Selected | |
| WACC / Discount Rate | 9.0% - 11.8% | 10.4% |
| Long-term Growth Rate | 2.5% - 4.5% | 3.5% |
| Fair Price | 6.80 - 13.33 | 8.94 |
| Upside | -47.8% - 2.3% | -31.4% |